← Back to Search

Music for Major Depressive Disorder

N/A
Waitlist Available
Led By Stéphane Richard-Devantoy, MD, PhD
Research Sponsored by Douglas Mental Health University Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1-month follow-up (8 weeks)
Awards & highlights

Study Summary

This trial will study the effects of music on people receiving ketamine IV infusions for depression that hasn't responded to other treatments.

Eligible Conditions
  • Major Depressive Disorder
  • Depression, Bipolar Disorder
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1-month follow-up (8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1-month follow-up (8 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in Systolic Blood Pressure
Secondary outcome measures
Change From Baseline in Beck Depression Inventory (BDI-II) Total Score to Follow-up
Change From Baseline in Beck Depression Inventory (BDI-II) Total Score to Last Treatment
Feeling suicidal (finding)
+22 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MusicExperimental Treatment1 Intervention
Music will be provided for participant's six 40 minute IV infusions of 0.5mg/kg ketamine administered over four weeks (biweekly for 2 weeks, then weekly for 2 weeks).
Group II: Usual CareActive Control1 Intervention
Participant's six 40 minute IV infusions of 0.5mg/kg ketamine administered over four weeks (biweekly for 2 weeks, then weekly for 2 weeks) will be administered as per usual care. That is, without music provided or permitted. Contact time with clinicians before, during, and after ketamine treatments will be matched.

Find a Location

Who is running the clinical trial?

Douglas Mental Health University InstituteLead Sponsor
29 Previous Clinical Trials
2,694 Total Patients Enrolled
Réseau québécois sur le suicide, les troubles de l'humeur et les troubles associésUNKNOWN
Stéphane Richard-Devantoy, MD, PhDPrincipal InvestigatorDouglas Mental Health University Insitute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Ontario
How old are they?
18 - 65
What site did they apply to?
Douglas Mental Health University Institute
Jewish General Hospital
What portion of applicants met pre-screening criteria?
Met criteria
~8 spots leftby Apr 2025